Matches in SemOpenAlex for { <https://semopenalex.org/work/W2732465293> ?p ?o ?g. }
- W2732465293 endingPage "67638" @default.
- W2732465293 startingPage "67626" @default.
- W2732465293 abstract "According to the CDC prostate cancer (CaP) has the highest incidence and second highest mortality rate amongst cancers in American men. Constitutive NF-κB activation is a hallmark of CaP and this pathway drives many pro-tumorigenic characteristics of CaP cells, including cell proliferation and survival. An activated NF-κB gene signature is predictive of CaP progression and biochemical recurrence following therapeutic intervention. However, the mechanisms that perpetuate NF-κB activation are incompletely understood. Genes that control NF-κB activity are rarely mutated in CaP suggesting that epigenetic mechanisms may contribute to constitutive NF-κB activation. microRNAs (miRs) epigenetically regulate many genes involved with NF-κB activation. IκBα is a direct inhibitor of NF-κB; it binds to and sequesters NF-κB in the cytoplasm resulting in functional inhibition. IκBα is a target gene of miR-30e* yet the expression and oncological impact of miR-30e* in CaP is unknown. We report that miR-30e* expression is elevated in multiple murine models of CaP and is most pronounced in late stage disease. miR-30e* drives CaP proliferation and tumor growth through inhibition of IκBα, which results in chronic activation of NF-κB. Additionally, we show that inhibition of miR-30e* improves chemotherapeutic control of CaP. Thus, miR-30e* may prove to be a novel clinical target whose inhibition leads to decreased CaP cell proliferation and sensitization of CaP cells to chemotherapeutics." @default.
- W2732465293 created "2017-07-14" @default.
- W2732465293 creator A5042261060 @default.
- W2732465293 creator A5063338223 @default.
- W2732465293 creator A5081026905 @default.
- W2732465293 creator A5082241355 @default.
- W2732465293 date "2017-06-28" @default.
- W2732465293 modified "2023-10-16" @default.
- W2732465293 title "miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth" @default.
- W2732465293 cites W144423133 @default.
- W2732465293 cites W1504155896 @default.
- W2732465293 cites W1578291413 @default.
- W2732465293 cites W1911919368 @default.
- W2732465293 cites W1968631483 @default.
- W2732465293 cites W1971284419 @default.
- W2732465293 cites W1973435573 @default.
- W2732465293 cites W1988959205 @default.
- W2732465293 cites W1993624611 @default.
- W2732465293 cites W1994637653 @default.
- W2732465293 cites W2010508270 @default.
- W2732465293 cites W2015009117 @default.
- W2732465293 cites W2017709907 @default.
- W2732465293 cites W2021505095 @default.
- W2732465293 cites W2023419617 @default.
- W2732465293 cites W2026114871 @default.
- W2732465293 cites W2026124308 @default.
- W2732465293 cites W2029533398 @default.
- W2732465293 cites W2039355568 @default.
- W2732465293 cites W2041193073 @default.
- W2732465293 cites W2046234516 @default.
- W2732465293 cites W2052908553 @default.
- W2732465293 cites W2055616071 @default.
- W2732465293 cites W2061466636 @default.
- W2732465293 cites W2071911843 @default.
- W2732465293 cites W2075172606 @default.
- W2732465293 cites W2075860675 @default.
- W2732465293 cites W2076136347 @default.
- W2732465293 cites W2091757706 @default.
- W2732465293 cites W2102507295 @default.
- W2732465293 cites W2106498871 @default.
- W2732465293 cites W2111923037 @default.
- W2732465293 cites W2121079193 @default.
- W2732465293 cites W2125200489 @default.
- W2732465293 cites W2129363220 @default.
- W2732465293 cites W2134887638 @default.
- W2732465293 cites W2137862731 @default.
- W2732465293 cites W2148516870 @default.
- W2732465293 cites W2156394189 @default.
- W2732465293 cites W2159368077 @default.
- W2732465293 cites W2160737079 @default.
- W2732465293 cites W2161112598 @default.
- W2732465293 cites W2162396830 @default.
- W2732465293 cites W2164942212 @default.
- W2732465293 cites W2167277055 @default.
- W2732465293 cites W2170552969 @default.
- W2732465293 cites W2171260596 @default.
- W2732465293 cites W2219105254 @default.
- W2732465293 cites W4245875102 @default.
- W2732465293 cites W4250417598 @default.
- W2732465293 cites W48300366 @default.
- W2732465293 doi "https://doi.org/10.18632/oncotarget.18795" @default.
- W2732465293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5620198" @default.
- W2732465293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28978058" @default.
- W2732465293 hasPublicationYear "2017" @default.
- W2732465293 type Work @default.
- W2732465293 sameAs 2732465293 @default.
- W2732465293 citedByCount "8" @default.
- W2732465293 countsByYear W27324652932018 @default.
- W2732465293 countsByYear W27324652932019 @default.
- W2732465293 countsByYear W27324652932021 @default.
- W2732465293 countsByYear W27324652932023 @default.
- W2732465293 crossrefType "journal-article" @default.
- W2732465293 hasAuthorship W2732465293A5042261060 @default.
- W2732465293 hasAuthorship W2732465293A5063338223 @default.
- W2732465293 hasAuthorship W2732465293A5081026905 @default.
- W2732465293 hasAuthorship W2732465293A5082241355 @default.
- W2732465293 hasBestOaLocation W27324652931 @default.
- W2732465293 hasConcept C104317684 @default.
- W2732465293 hasConcept C121608353 @default.
- W2732465293 hasConcept C145059251 @default.
- W2732465293 hasConcept C190283241 @default.
- W2732465293 hasConcept C2777730290 @default.
- W2732465293 hasConcept C2780192828 @default.
- W2732465293 hasConcept C41091548 @default.
- W2732465293 hasConcept C502942594 @default.
- W2732465293 hasConcept C54355233 @default.
- W2732465293 hasConcept C62112901 @default.
- W2732465293 hasConcept C62478195 @default.
- W2732465293 hasConcept C71924100 @default.
- W2732465293 hasConcept C86803240 @default.
- W2732465293 hasConcept C95444343 @default.
- W2732465293 hasConceptScore W2732465293C104317684 @default.
- W2732465293 hasConceptScore W2732465293C121608353 @default.
- W2732465293 hasConceptScore W2732465293C145059251 @default.
- W2732465293 hasConceptScore W2732465293C190283241 @default.
- W2732465293 hasConceptScore W2732465293C2777730290 @default.
- W2732465293 hasConceptScore W2732465293C2780192828 @default.
- W2732465293 hasConceptScore W2732465293C41091548 @default.